According to SPER Market Research, the epilepsy monitoring devices market estimated to reach USD 724 million by 2030 with a CAGR of 4.5%.
Rising prevalence of epilepsy across the globe is a key driver for the growth of epilepsy monitoring devices market.
Epilepsy monitoring devices are used to continuously monitor the seizures in an epilepsy patient. The device essentially notifies the healthcare providers or caretakers when the seizure happens in the related patients.
According to the WHO, global burden of epilepsy is 0.5% of diseases prevailing globally. Epilepsy requires years of treatment which costs economic implications and mortality in some patients. About 80% of epilepsy patients are from low or middle-income countries. The poor healthcare infrastructure also restricts the patients from getting necessary treatment and leads to premature deaths.
The epilepsy monitoring devices are also available in wearable type which makes it more user-friendly and effective in continuous monitoring. Factors such as increasing awareness for neurological disorders, rising demand for continuous monitoring and rising use of wearable devices contribute to the growth of this market during the forecast period.
The conventional devices market is the largest product segment by share in this market. The large share of this segment is mainly ascribed by rising demand for minimally invasive procedures, growing awareness for neurological disorders and increasing demand for continuous monitoring of brain. North America dominated the market by regional segmentation owing to rising prevalence of neurological disorders, government initiatives, better reimbursement policies and increasing funding for Research and Development in healthcare field.
The global epilepsy monitoring devices market study provides market data by competitive landscape, revenue analysis, market segments and detailed analysis of key market players such as Abbott Laboratories, Inc., Advanced Brain Monitoring, Aleva Neurotherapeutics, BioSerenity, Boston Scientific Corporation, Cadwell Industries, Inc., CGX, Compumedics Limited, Drägerwerk AG & Co. KGaA, Emotiv, Empatica, Inc., Lifelines Neuro Company, LLC, LivAssured B.V., Masimo Corporation, MC10, Inc., Medpage, Ltd., Medtronic Plc, Mindray Medical International Ltd., Mitsar Co., Ltd., mjn Neuroserveis S.L., Natus Medical, Inc., Neurosoft, NeuroWave Systems, Inc., Nihon Kohden Corporation, Rimed, The Magstim Co. Ltd.
SPER Market Research study aims to provide market dynamics, demand and supply with yearly forecast to 2030. This report provides data for growth estimates and forecasts for product segments- Conventional devices and Wearable devices and by End user segment- Hospitals & Clinics, Home Care Settings and Others. This report also provides the data for key regional segments of North America, Europe, Asia-Pacific and Rest of the World.
This study also encompasses various drivers and restraining factors for this market for the forecast period. Various growth opportunities are also discussed in the report.